CA
CLX icon

Crewe Advisors’s Clorox CLX Stock Holding History

Crewe Advisors’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.77K Buy
50
+2
+4% +$192 ﹤0.01% 892
2026
Q1 		$4.97K Hold
48
– – ﹤0.01% 781
2025
Q4 		$4.84K Sell
48
-355
-88% -$38.5K ﹤0.01% 732
2025
Q3 		$49.7K Buy
403
+48
+14% +$5.96K ﹤0.01% 383
2025
Q2 		$42.6K Hold
355
– – 0.01% 305
2025
Q1 		$52.3K Hold
355
– – 0.01% 267
2024
Q4 		$57.7K Hold
355
– – 0.01% 269
2024
Q3 		$57.8K Hold
355
– – 0.01% 284
2024
Q2 		$48.4K Hold
355
– – 0.01% 374
2024
Q1 		$54.4K Buy
+355
New +$53K 0.01% 356
2023
Q3 		– Sell
-359
Closed -$57.1K – 647
2023
Q2 		$57.1K Buy
359
+4
+1% +$645 0.01% 259
2023
Q1 		$56.2K Buy
+355
New +$53.2K 0.01% 298
2022
Q4 		– Sell
-10
Closed -$1K – 1069
2022
Q3 		$1K Buy
+10
New +$1.44K ﹤0.01% 1123
2020
Q4 		– Sell
-7
Closed -$1K – 486
2020
Q3 		$1K Buy
+7
New +$1.56K ﹤0.01% 563

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Crewe Advisors's CLX Position: Q2 2026 in Review

Crewe Advisors increased its Clorox (CLX) stake by 4.2% in Q2 2026, buying an estimated $192 and bringing the position to 50 shares worth $4.77K. The position accounts for ﹤0.01% of the portfolio, ranked #892.

Crewe Advisors first reported a position in CLX in Q3 2020 and has held it in 14 quarters since. The position peaked at $57.8K in Q3 2024. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Crewe Advisors held 50 shares of Clorox worth $4.77K as of Q2 2026.
  • Crewe Advisors bought 2 Clorox shares in Q2 2026, an estimated $192.
  • Clorox made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #892 holding.
  • Crewe Advisors first reported a position in Clorox in Q3 2020 and has held it in 14 quarters since.
  • Crewe Advisors's Clorox position peaked at $57.8K in Q3 2024.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.